Lasa Supergenerics Limited (BOM:540702)
India · Delayed Price · Currency is INR 5.39
0.00 (0.00%)
At close: Oct 5, 2026
Lasa Supergenerics Market Cap
Lasa Supergenerics has a market cap or net worth of 266.54 million as of October 7, 2026. Its market cap has decreased by 54.76% in one year.
Market Cap
266.54M
Enterprise Value
357.04M
Revenue
65.20M
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since September 22, 2017, Lasa Supergenerics's market cap has decreased from 3.53B to 266.54M, a decrease of -92.46%. That is a compound annual growth rate of -24.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 266.54M | -43.64% |
| Dec 31, 2025 | 472.96M | -62.89% |
| Dec 31, 2024 | 1.27B | -14.92% |
| Dec 29, 2023 | 1.50B | 9.45% |
| Dec 30, 2022 | 1.37B | -50.95% |
| Dec 31, 2021 | 2.79B | -18.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bafna Pharmaceuticals | 9.14B |
| Amanta Healthcare | 7.76B |
| Valiant Laboratories | 6.77B |
| Nectar Lifesciences | 2.04B |
| Brooks Laboratories | 1.60B |
| Par Drugs and Chemicals | 1.55B |
| Balaxi Pharmaceuticals | 1.26B |
| Alpa Laboratories | 1.24B |